222 reports of this reaction
3.0% of all PERPHENAZINE reports
#3 most reported adverse reaction
WEIGHT INCREASED is the #3 most commonly reported adverse reaction for PERPHENAZINE, manufactured by Actavis Pharma, Inc.. There are 222 FDA adverse event reports linking PERPHENAZINE to WEIGHT INCREASED. This represents approximately 3.0% of all 7,483 adverse event reports for this drug.
Patients taking PERPHENAZINE who experience weight increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT INCREASED is a less commonly reported adverse event for PERPHENAZINE, but still significant enough to appear in the safety profile.
In addition to weight increased, the following adverse reactions have been reported for PERPHENAZINE:
The following drugs have also been linked to weight increased in FDA adverse event reports:
WEIGHT INCREASED has been reported as an adverse event in 222 FDA reports for PERPHENAZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT INCREASED accounts for approximately 3.0% of all adverse event reports for PERPHENAZINE, making it one of the most commonly reported side effect.
If you experience weight increased while taking PERPHENAZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.